| 发明名称 |
USE OF CHEMICALLY MODIFIED HEPARIN DERIVATES IN SICKLE CELL DISEASE |
| 摘要 |
The present invention relates to chemically modified heparin for use in the treatment of sickle cell disease, with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw) between about 6.5 and 9.5 kDa. |
| 申请公布号 |
EP2794666(A1) |
申请公布日期 |
2014.10.29 |
| 申请号 |
EP20120859384 |
申请日期 |
2012.12.19 |
| 申请人 |
DILAFORETTE AB |
发明人 |
EKRE, HANS-PETER;LEITGEB, ANNA;WAHLGREN, MATS;PIKAS, DAGMAR |
| 分类号 |
C08B37/10;A61K31/727;A61K45/06;A61P7/00;C08B37/00 |
主分类号 |
C08B37/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
